Leinco Technologies offers a comprehensive selection of high-affinity drug antibodies specifically engineered for use in In Vitro Diagnostic (IVD) applications. These monoclonal antibodies serve as the critical foundation for sensitive and specific immunoassays, including therapeutic drug monitoring (TDM) and drugs of abuse (DoA) testing. Manufactured under a strict ISO 13485:2016 quality management system, our reagents provide the lot-to-lot consistency and high purity required for commercial diagnostic platforms, from lateral flow assays to sandwich ELISAs. By partnering with Leinco, diagnostic manufacturers gain access to a robust supply chain of premium raw materials designed to meet the rigorous regulatory standards of the global IVD market.